Significant Increase in Salivary Substance P Level after a Single Oral Dose of Cevimeline in Humans
Figure 3
Effects of a single oral dose of cevimeline (•) or placebo (°) on salivary levels of substance P (SP) (a), calcitonin gene-related peptide (CGRP) (b), and vasoactive intestinal polypeptide (VIP) immunoreactive substance (c). Values are means ± SD, . *, **, versus placebo at the same time point.